We have demonstrated that CAV1 expression has a positive correlation with glioma patients’ outcomes and dig out its working mechanisms: (1) The expression of CAV1 has a positive relation with the progression of glioma and a negative relation with glioma patients’ survival. Here, CAV1 is linked to central nervous system cancer.